KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Invested Capital: 2012-2025

Historic Invested Capital for Precigen (PGEN) over the last 13 years, with Sep 2025 value amounting to $134.8 million.

  • Precigen's Invested Capital rose 143.35% to $134.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.8 million, marking a year-over-year increase of 143.35%. This contributed to the annual value of $38.5 million for FY2024, which is 67.50% down from last year.
  • According to the latest figures from Q3 2025, Precigen's Invested Capital is $134.8 million, which was up 466.40% from -$36.8 million recorded in Q2 2025.
  • Over the past 5 years, Precigen's Invested Capital peaked at $349.3 million during Q1 2021, and registered a low of -$36.8 million during Q2 2025.
  • For the 3-year period, Precigen's Invested Capital averaged around $86.2 million, with its median value being $97.0 million (2024).
  • Examining YoY changes over the last 5 years, Precigen's Invested Capital showed a top increase of 143.35% in 2025 and a maximum decrease of 185.20% in 2025.
  • Over the past 5 years, Precigen's Invested Capital (Quarterly) stood at $287.3 million in 2021, then slumped by 41.01% to $169.5 million in 2022, then plummeted by 30.08% to $118.5 million in 2023, then plummeted by 67.50% to $38.5 million in 2024, then skyrocketed by 143.35% to $134.8 million in 2025.
  • Its Invested Capital was $134.8 million in Q3 2025, compared to -$36.8 million in Q2 2025 and -$14.1 million in Q1 2025.